Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 16/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3152179 | 0.76 | HCAR2 (0.42) | KDM4CHCAR2KMT2ATSHRSLC6A4 | |
| SCHEMBL30107036 | 0.74 | HCAR2 (0.42) | KDM4CHCAR2KMT2ATSHR | |
| SCHEMBL26963252 | 0.74 | HCAR2 (0.41) | KDM4CHCAR2KMT2ATSHRSLC6A4 | |
| SCHEMBL8807725 | 0.67 | HCAR2 (0.39) | HCAR2KMT2ATSHR | |
| SCHEMBL8842823 | 0.67 | RAB9A (0.50) | KMT2A | |
| SCHEMBL29956356 | 0.67 | HCAR2 (0.53) | KDM4CHCAR2KMT2ATSHR | |
| SCHEMBL28543309 | 0.66 | HCAR2 (0.45) | KDM4CHCAR2 | |
| SCHEMBL18660404 | 0.66 | KDM4C (1.00) | KDM4CKMT2ATSHR | |
| SCHEMBL1816267 | 0.66 | HCAR2 (0.50) | KDM4CHCAR2KMT2ATSHR | |
| SCHEMBL7234538 | 0.65 | HCAR2 (0.57) | HCAR2KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505204-A | Multifunctional flame-retardant anti-dripping copolyester and preparation method and application thereof | 四川大学 | 2025-02-25 | — | — | CN | disclosed |
| US-6617347-B1 | Substituted pyrazoles are treatment of Type II diabetes and obesity. | ELI LILLY AND COMPANY | 2003-09-09 | — | — | US | disclosed |
| EP-1036064-A4 | SELECTIVE BETA 3-ADRENERGIC AGONISTS | LILLY CO ELI (US) | 2002-11-27 | — | — | EP | disclosed |
| US-6232337-B1 | USEFUL IN THE TREATMENT OF TYPE II DIABETES AND OBESITY | ELI LILLY AND COMPANY | 2001-05-15 | — | — | US | disclosed |
| EP-1036064-A1 | SELECTIVE BETA 3-ADRENERGIC AGONISTS | ELI LILLY AND COMPANY (US) | 2000-09-20 | — | — | EP | disclosed |
| US-6046227-A | USEFUL IN THE TREATMENT OF TYPE II DIABETES AND OBESITY; A SUBSTITUTED PYRAZINE COMPOUND | ELI LILLY AND COMPANY (US) | 2000-04-04 | — | — | US | disclosed |
| WO-1999029672-A1 | SELECTIVE β3 ADRENERGIC AGONISTS | ELI LILLY AND COMPANY (US) | 1999-06-17 | — | — | WO | disclosed |
| EP-0921120-A1 | Selective beta 3 adrenergic agonists | ELI LILLY AND COMPANY (US) | 1999-06-09 | — | — | EP | disclosed |